Spatial Characterization of Immunosuppressive Microenvironment in Patients with PD-L1 Discordant Response to Pembrolizumab in Advanced Non-small Cell Lung Cancer
Seong-Eun Kim
Asan Medical Center
Korea
A-0115
14:55-15:05
Delta-like Ligand 3 (DLL3)-based Enrichment Enables Sensitive and Specific Detection of Circulating Tumor Cells During Immunotherapy in Small-cell Lung Cancer
Hyung-Joo Oh
Chonnam National University Medical School and Hwasun Hospital
Korea
A-0088
15:05-15:15
Cereblon (CRBN) Suppresses Lung Adenocarcinoma Cell Migration and Invasion by Facilitating the Degradation of Cystathionine Beta-Synthase (CBS)
Hyeon-Seung Yoon
Gwangju Institute Of Science And Technology
Korea
A-0060
15:15-15:25
Ganoderic Acid-Chitosan Lipid Nanoparticles Attenuate Benzopyrene-Induced Lung Cancer via Alteration of PI3K/Akt/mTOR, NF-kB and MAPK/ERK Signaling Pathway
Vikas Kumar
Sam Higginbottom University Of Agriculture, Technology & Sciences
India
A-0022
15:25-15:35
In Vivo CRISPR Activation Screens Reveal Drivers of Chemoresistance in Small Cell Lung Cancer
Jae Heun Chung
Pusan National University Yangsan Hospital
Korea
Oral Presentation 2
November 7 (Fri), 09:10-10:00
ROOM C (Crystal Ballroom 1)
Oral Present
Abstract No.
Presentation Time
Abstract Title
Presenter Name
Affiliation
Country
A-0103
09:10-09:20
Impact of Quitting Smoking at Diagnosis on Overall Survival in Lung Cancer Patients: A Comprehensive Meta-Analysis
Dongwon Park
Hanyang University Medical Center
Korea
A-0151
09:20-09:30
Transbronchial Mediastinal Cryobiopsy for Mediastinal Lesions: The First Single-Center Experience in South Korea
Min Jee Kim
Asan Medical Center
Korea
A-0021
09:30-09:40
Combining Deep Learning Radiomics with Clinical Data for Preoperative Prediction of STAS in Stage IA Lung Adenocarcinoma: a Multicenter Study
Xiaocui Liu
Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology
Localized Defense Programs Underlie Prognostic Divergence in GGO and Solid Lung Adenocarcinoma
Han Sanghyun
Chungbuk National University Hospital
Korea
Oral Presentation 3
November 7 (Fri), 10:25-11:25
ROOM C (Crystal Ballroom 1)
Oral Present
Abstract No.
Presentation Time
Abstract Title
Presenter Name
Affiliation
Country
A-0072
10:25-10:35
Effectiveness and Radiation Pneumonitis of Stereotactic Body Radiation Therapy in High-Risk Patients with Early-Stage Non-Small Cell Lung Cancer
Yoo Kyung Choi
The Catholic University of Korea Seoul St. Mary's Hospital
Korea
A-0048
10:35-10:45
Identification of a novel Golgi Apparatus signature to prognostic stratification and integrative analyses in lung adenocarcinoma
Haoran Li
Sichuan Cancer Hospital
China
A-0077
10:45-10:55
Deep Learning-Driven Reconstruction of Lineage and Immune Plasticity Trajectories in Small Cell Lung Cancer Using Multi-Omics Data Integration
Rifaldy Fajar
The Integrated Mathematical, Computational, And Data Science For Biomedicine Research Foundation
Indonesia
A-0054
10:55-11:05
Tislelizumab vs Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer: Literature Review of Indirect Treatment Comparisons
Ji-Youn Han
National Cancer Center
Korea
A-0025
11:05-11:15
Predictive Value of Inflammatory Biomarkers in EGFR-Mutant NSCLC Treated with Lazertinib: An Interim Analysis of a Prospective Real-World Study (ORIENT)
Seung Hyeun Lee
Kyung Hee University Medical Center
Korea
A-0148
11:15-11:25
Integrated Gene Expression and Network Analysis Identifies Key Pathways in Small Cell Lung Cancer
Nadyatul Husna
Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang
Indonesia
Basic & Translational Research / Biology / Pathology
Basic & Translational Research / Biology / Pathology
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0215
PE1-01
Clinical Relevance of Pleural Tissue Debris Incidentally Obtained During Catheter Drainage for Pleural Effusion
Jiwon Kim
Kyung Hee University Medical Center
Korea
A-0189
PE1-02
A Radiomics-based Nomogram for Preoperative Prediction of Pathological Subtypes in Nodular Lung Adenocarcinoma: a Multicenter Study
Xiaocui Liu
Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology
China
A-0161
PE1-03
Dual Modulation of Redox and Immune Signaling in Lung Cancer via Pharmacoinformatic Study of Benzothiazepine-Based Immunomodulators Targeting Nrf2 and JAK2-JH1
Rizki Rachmad Saputra
Universitas Palangka Raya
Indonesia
A-0131
PE1-04
Molecular Adaptation Reveals Metabolic and Stress Response Bypass Pathways in Erlotinib-Resistant Non-Small Cell Lung Cancer Subclones
Nadyatul Husna
Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang
Indonesia
A-0118
PE1-05
Uncovering Multi-Layered Resistance Mechanisms to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer
Nadyatul Husna
Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang
Indonesia
A-0093
PE1-06
Natural Triterpenoids of Peronema canescens as Dual Inhibitors of AKT1 and ERK1/2: A Structure-Based Approach for Overcoming Lung Cancer
Rizki Rachmad Saputra
Universitas Palangka Raya
Indonesia
A-0076
PE1-07
Development of a Novel Inhibitor Against nRAS-Mutated Lung Cancers.
Vikas Kumar
Aiims New Delhi
India
A-0059
PE1-08
Solid Lipid Nanoparticle of Ganodric acid ameliorate benzopyrene induced lung cancer in rats Via Alteration of Nrf2/HO-1 Signaling pathway
V Kumar
Shalom Institute Of Health & Allied Sciences
India
A-0236
PE1-09
Decoding the Role of myomiR-206 in Lung Cancer Cachexia and Its Correlation with IL-6 Signaling
Divo Helmizar
Stan / Perbendaharaan Negara
Indonesia
A-0233
PE1-10
Decoding Hematologic Paraneoplastic Syndromes in Lung Cancer: A Critical Approach to Early Diagnosis
Aryofri Afan
Andalas University
Indonesia
A-0220
PE1-11
Establishment of a Lung Organoid Library from Diverse Clinical Samples for Advanced Disease Modeling
Joo-Eun Lee
Chungnam National University Hospital
Korea
A-0208
PE1-12
Role of PFKFB3 in Maintaining Redox Homeostasis and DNA Integrity in Non-Small Cell Lung Cancer Cells Treated with EGFR-TKIs
Brijalkumar Patel
Gmers Medical College
India
A-0207
PE1-13
Follicular lymphoma presenting with solitary pulmonary nodule: two case reports
Heae Surng Park
Ewha Womans University Medical Center
Korea
A-0181
PE1-14
Nutritional and Lifestyle Interventions in Lung Cancer Prevention and Survivorship in Indonesia
Helen Try Juniasti
Cendrawasih University
Indonesia
A-0174
PE1-15
Enhancing Quality of Life in Lung Cancer Patients: Integrating Palliative Care with Immunotherapy and Targeted Therapy
Yesika Simbolon
Atmajaya University
Australia
A-0134
PE1-16
Genetic Analysis of Compositions For Diagnosing Lung Cancer Comprising Peptide Nucleic Acid Probe Complementary To Lung Cancer Related Mutations
Ramlah Ramlah
Universitas Sulawesi Barat esia
Indonesia
A-0100
PE1-17
Spread Through Air Spaces in EGFR-mutated Lung Adenocarcinomas: Prevalence and Prognostic Significance
Yeon Bi Han
Seoul National University Bundang Hospital
Korea
A-0095
PE1-18
Decoding Alternative Splicing-Driven Immune Escape in Rare Lung Adenocarcinoma Subtypes Using Deep Learning and Minor Spliceosome Signatures
Rini Winarti
Yogyakarta State University
Indonesia
A-0081
PE1-19
Integrated Multi-Omics Profiling Identifies CEBPA as an Aging-Related Prognostic Biomarker in NSCLC
Jiaqi Zhu
Affiliated Hospital Of Nantong University
China
A-0038
PE1-20
Investigating the Role and Mechanisms of USP18-Mediated YAP Deubiquitination in Radiation-Induced Lung Injury
Haochun Guo
Zhongda Hospital, Medical School Of Southeast University
China
A-0037
PE1-21
Exploring the protection effects of Taxifolin on alleviating radiation-induced lung injury basing on USP18
Haochun Guo
Zhongda Hospital, Medical School Of Southeast University
China
A-0035
PE1-22
Comprehensive Analysis of Matrisome-Related Genes Reveals Prognostic Value and Immune Landscape in Lung Cancer
Hou Wang
Ningbo No.2 Hospital
China
Big Data & AI
Big Data & AI
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0096
PE1-23
A Peritumor-based Model Combining 3D Deep Learning and Radiomics for Preoperatively Predicting STAS in Invasive Lung Adenocarcinoma: a Multicenter Study
Xiaocui Liu
Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology
China
A-0244
PE1-24
Machine Learning Algorithms' Use in Plasma Biomarker-Based Lung Cancer Diagnosis
Siska Azizah
Baiturrahmah Universitya
Indonesia
A-0211
PE1-25
An AI-powered holotomography platform for predicting drug response in patient-derived lung cancer organoids
Mahn Jae Lee
Chungnam National University Hospital
Korea
A-0135
PE1-26
Development of Big Data for Predecting Lung Cancar (Study in Asia)
Rara Yulianda
Sulthan Thaha Saifuddin Islamic State University
Indonesia
A-0132
PE1-27
Enhancing using Artificial Intelligence in Detecting Lung Cancer in Asia
Rani Marsyanda
Sultan Thaha Saifuddin Islamic State University
Indonesia
A-0120
PE1-28
A Comprehensive Review of Legal and Ethical in the Implementation of AI & Big Data in Lung Cancer Diagnosis
Ferza Alfath
Alumnus Universitas Andalas
Indonesia
A-0119
PE1-29
AI-Driven Multi-Modal Prediction of Post-Surgical Recurrence in Brain-Metastatic Lung Adenocarcinoma: Integrating Tumor Dormancy, Stromal Remodeling, and TME Immune Exclusion Signals
Elfiany Syafruddin
Blk Muhammadiyah University
Indonesia
A-0075
PE1-30
Comparative Risk of Neurological Adverse Events Between PD-1 and PD-L1 Inhibitors in Korean Lung Cancer Patients: A Nationwide Cohort Study
Seung Hyeun Lee
Kyung Hee University Medical Center
Korea
A-0067
PE1-31
Applying machine learning (ML) and artificial intelligence (AI) techniques to predict the risk of lung cancer in region of Chhattisgarh.
Manvendra Singh
Hmfa Miet
India
Others
Others
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0170
PE1-32
Assessment of the association between expression of Cyclin D1 protein with the clinicopathological characteristics and prognosis of lung cancer
Usha J Satanee
Nanduba Medical Center
India
A-0127
PE1-33
Trends of positive rates of initial screening and repeated screening in national organized population-based lung cancer screening in Korea
Nayoung Lee
National Cancer Center
Korea
A-0217
PE1-34
Economic Burden and Cost-Effectiveness of Lung Cancer Management in Indonesia: Evidence from Smoking-Attributable Mortality and EGFR-Targeted Therapies
Pisi Bethania Titalessy
Universitas Cenderawasih
Indonesia
A-0117
PE1-35
Highly Sensitive Digital Profiling of Tumor-derived Extracellular Vesicle RNA for EML4-ALK Mutations in Non-small Cell Lung Cancer
Beomseok Lee
Labspinner, Inc.
Korea
A-0173
PE1-36
Impact Evaluation of Cigarette Excise and Pricing on Smoking Habits and Lung Cancer Disease in Indonesia
Lintong Hottua Simbolon
The Pranala Institute
Indonesia
Pulmonology / Endoscopy
Pulmonology / Endoscopy
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0240
PE1-37
ECMO as a Procedural Bridge for Malignant Airway Obstruction
Hyeong Jun Cho
The Catholic University of Korea Seoul St. Mary's Hospital
Korea
A-0230
PE1-38
Enhancing Early-Stage Lung Cancer Diagnosis: The Role of Bronchoscopic Biomarkers in Improving Accuracy and Personalizing Treatment
Roland Helmizar
Faculty Of Medicine, Baiturrahmah University
Indonesia
A-0121
PE1-39
Initial Experience of EBUS-TBNA in Mongolia: Diagnosing 13R Squamous Cell Carcinoma Without Radial Ultrasound
Davaajav Nyamluvsan
The First Central Hospital of Mongolia
Mongolia
Radiology / Staging / Screening / Epidemiology
Radiology / Staging / Screening / Epidemiology
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0232
PE1-40
Long-Term Projections of Tracheal, Bronchus, and Lung Cancer in Indonesia’s Productive-Age Population
Najwa Aisya Putri
International Open University
Indonesia
A-0225
PE1-41
Contrasting Mortality Patterns of Lung Cancer in Young Adults (25-29 Years) Across Global Socio-Demographic Contexts, 2015-2021
Najwa Aisya Putri
International Open University
Indonesia
A-0223
PE1-42
Divergent Global Trends in Lung Cancer Mortality Among Young Adults (25-29 Years) by Socio-Demographic Index: Projections to 2050
Najwa Aisya Putri
International Open University
Indonesia
A-0205
PE1-43
Mapping the Burden of Tracheal, Bronchus, and Lung Cancer: Age-Based and SDI-Level Comparisons from the GBD 2021
Nabila Zahra Athirah
Islamic University Of Indonesia
Indonesia
A-0204
PE1-44
Unveiling the Burden of Smoking on Lung Cancer in Indonesia: A Quantitative Assessment from 2017 to 2021
Najwa Aisya Putri
International Open University
Indonesia
A-0031
PE1-45
Indoor air pollution and risk of hypopharyngeal/laryngeal and lung cancers in New Delhi, India
Monirujjaman Biswas
Jawaharlal Nehru University
India
A-0030
PE1-46
Examining the differences between non-smokers and smokers of lung cancer: Insights from a Tertiary Centre in Delhi, India
Monirujjaman Biswas
Jawaharlal Nehru University
India
A-0020
PE1-47
Trends and Survival Outcomes of Lung Cancer Surgery in South Korea, 2015-2019
Chanwoo Kim
Chungbuk National University
Korea
A-0243
PE1-48
Regional Trends in Lung Cancer in Southeast Asia: Analysis of Mortality Proportion, Daily Life Expectancy (DALYs), and Prevalence
Derizal Derizal
Ip Trisakti
Indonesia
A-0239
PE1-49
Identification of Environmental, Behavioral, and Metabolic Risk Factors for Lung Cancer Mortality: A Statistical Approach
Putri Ayu
Andalas University
Indonesia
A-0201
PE1-50
Preventing Chronic Lung Disease Early: Evidence of the Impact of Parenting and Mental Health from the Indonesian Family Life Survey
Derizal Derizal
Ip Trisakti
Indonesia
A-0087
PE1-51
User Satisfaction and Reading Efficiency of an AI-Based Quality Control System in Korean National Lung Cancer Screening
Kang Jegu
National Cancer Center
Korea
A-0086
PE1-52
Urban-Rural Disparities in Lung Cancer Diagnosis and Treatment in Indonesia: A Nationwide Review
Rinita Istiqomah
Universitas Jambi
Indonesia
A-0074
PE1-53
Single Round LDCT Screening in Men Aged 70 Years: Prevalence of Pulmonary Nodules and Lung Cancer Detection
Hyerin Kang
Dongtan Sacred Heart Hospital
Korea
A-0056
PE1-54
Air Pollution and Lung Cancer in a Changing Climate Through Projected Risks and Molecular Impacts of PM2.5 Exposure
Firdian Makrufardi
Integrated Medical, Molecular, And Data Science Research Foundation
Indonesia
A-0027
PE1-55
Sex-Specific Associations of Total Bilirubin, ALBI, and PALBI with Lung Cancer Risk: Interactions with Smoking and Alcohol
Jong Won Shin
Asan Medical Center
Korea
A-0026
PE1-56
Risk and Incidence of Drug-Induced Interstitial Lung Disease Associated with Anti-Neoplastic Therapy: A Nationwide Population-Based Study in Korea
Seung Hyeun Lee
College of Medicine, Kyung Hee University, Kyung Hee University Hospital
Korea
A-0019
PE1-57
Association between Creatinine and Lung Cancer Risk in Men Smokers: A Comparative Analysis with Antioxidant Biomarkers from the KCPS-II Cohort
Jong Won Shin
Asan Medical Center
Korea
Early / Locally Advanced Non-Small Cell Lung Cancer
Early / Locally Advanced Non-Small Cell Lung Cancer
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0196
PE2-01
FASN's Role in Lung Cancer Stem Cells: A Study of EGFR-Mutant Non-Small Cell Lung Cancer Cells
Nilamkumari Naginbhai Patel
Esis General Hospital
India
A-0171
PE2-02
Financial Management and Clinical Outcomes in Early and Locally Advanced NonSmall Cell Lung Cancer (NSCLC)
Fitri Kurnia
Universitas Muhammadiyah Sumatera Barat
Indonesia
A-0166
PE2-03
The diagnostic accuracy of microRNA 21 as compare to histopathological diagnosis in patients with non small cell lung cancer.
Jeegnesh Bholabhai Satanee
Nanduba Medical Center
India
A-0158
PE2-04
Geriatric Screening Tools in Older Patients Undergoing Concurrent Chemoradiotherapy for Locally Advanced non-Small Cell Lung Cancer
Yong-Hyub Kim
Chonnam National University Medical School and Hwasun Hospital
Korea
A-0124
PE2-05
Hexosamine Biosynthetic Pathway-Mediated Cytoskeletal Reorganization: A Potential Metabolic Mechanism Underlying Early-Stage Non-Small Cell Lung Cancer
Lara Beatrice Sunga
University Of The Philippines Diliman
Philippines
A-0104
PE2-06
Prognostic Value of EGFR Mutation in Resected NSCLC: A Meta-Analysis of Literature Published 2015-2025
Soo Han Kim
Pusan National University Hospital
Korea
A-0057
PE2-07
Prognostic Significance of Circulating microRNAs in Non-Small Cell Lung Cancer Patients
Widia Sari
Faculty Of Medicine, Universitas Baiturrahmah
Indonesia
Mesothelioma / Thymic & Other Thoracic Malignancies
Mesothelioma / Thymic & Other Thoracic Malignancies
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0203
PE2-08
Uncovering the Growing Burden of Mesothelioma: A Five-Year Analysis in Southeast Asia Using CAGR
Nabila Zahra Athirah
Islamic University Of Indonesia
Indonesia
A-0202
PE2-09
Prognostic Impact of Histologic Subtype, Age, and Systemic Immune-Inflammation Index in Surgically Treated Malignant Pleural Mesothelioma
Song Ee Park
The Catholic University of Korea Seoul St. Mary's Hospital
Korea
A-0200
PE2-10
Exploring Mesothelioma Outcomes Among Working-Age Women: A Five-Year Global Study of Prevalence and Mortality Trends
Najwa Aisya Putri
International Open University
Indonesia
A-0177
PE2-11
Correlation of CT and PET Imaging Responses with Pathological Outcomes after Neoadjuvant Treatment for Thymic Tumors
Hyeon Seok Choi
Seoul National University Hospital
Korea
A-0102
PE2-12
Rare Mutation, Real Impact: Durable Response In EGFR-Mutated Sarcomatoid Lung Cancer
Noor Nabila Binti Mohamad
National Cancer Institute
Malaysia
A-0090
PE2-13
Mathematical Modeling of Treg-TAM Crosstalk and TNFR2 Immunotherapy Timing in Thymic and Mesothelial Tumors Post-Chemotherapy
Prihantini Prihantini
The Integrated Mathematical, Computational, And Data Science For Biomedicine Research Foundation
Indonesia
A-0024
PE2-14
Malignant Pleural Mesothelioma at Pham Ngoc Thach Hospital in 10-Year Retrospective Study
Nguyen Son Lam
Pham Ngoc Thach Hospital (retired)
Vietnam
Radiotherapy
Radiotherapy
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0146
PE2-15
Molecular Insights into Melastoma malabathricum’s Anticancer Potential: Advancing Radiotherapy Efficacy in Early-Stage Lung Carcinoma
Muhammad Priyadi
Universitas Palangka Raya
Indonesia
A-0179
PE2-16
Prognostic Impact of Dose to Circulating Blood Cells in Non-Small Cell Lung Cancer Patients after Chemoradiotherapy
Byung-Hee Kang
Ewha Womans University Medical Center
Korea
A-0144
PE2-17
Radiogenomics in Personalised Radiotherapy: Correlation Between Gene Expression and Clinical Outcome
Muhammad Irzaq
Alumnus Padang State University
Indonesia
Surgery
Surgery
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0079
PE2-18
A Comparative Analysis of Sublobar versus Lobar Resection for Early-Stage Non-Small Cell Lung Cancer in Octogenarian Patients
Sangil Yun
Seoul National University
Korea
A-0227
PE2-19
Racial and Ethnic Disparities in Surgical Management of Early-Stage Non-Small Cell Lung Cancer: A population-Based Analysis
Ahmed Almezaine
Ministry Of Health
Egypt
A-0182
PE2-20
Long-Term Outcomes After ICU Discharge Among Lung Cancer Patients: A Longitudinal Analysis of Physical, Cognitive, and Emotional Health Across Age
Silmi Rahmani
The Pranala Institute
Indonesia
A-0176
PE2-21
Caregiver Dynamics and Surgical Recovery in Lung Cancer: Perception, Knowledge, Attitude, and Patient Quality of Life in Indonesia
Are Bevacizumab Biosimilars Clinically Equivalent in Advanced Non-Squamous NSCLC? Evidence from a Meta-Analysis of 14 RCTs
Mohamed Hamouda Elkasaby
Faculty Of Medicine, Al-Azhar University
Egypt
A-0164
PE3-02
Investigating the Role of Autophagy-Flux Molecules in Overcoming EGFR TKI Resistance in NSCLC
Seoree Kim
The Catholic University of Korea Bucheon St. Mary's Hospital
Korea
A-0123
PE3-03
Designing Targeted Therapies for Lung Cancer using Monobody Scaffolds Targeting sEGFR
Tushar Kushwaha
All India Institute Of Medical Sciences
India
A-0116
PE3-04
Comparison of TKI Monotherapy versus TKI Combined with Radiotherapy or Surgery in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer
Eun Hye Lee
Yonsei University College of Medicine
Korea
A-0092
PE3-05
Predictive Value of Baseline Peripheral Lung SUVmax for Immune-Related Pneumonitis in Lung Cancer Patients on Immunotherapy
Chaeuk Chung
Chungnam National University Hospital
Korea
A-0091
PE3-06
Real-World Outcomes of Brigatinib vs Alectinib as Second-Line Therapy After Crizotinib in Advanced ALK-Positive NSCLC
Min Jee Kim
Asan Medical Center
Korea
A-0061
PE3-07
Immune Gene Signatures Predict Response to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer
Nadyatul Husna
Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang
Indonesia
A-0023
PE3-08
Efficacy of First-Line Osimertinib in Vietnamese Patients with Stage IV EGFR-Mutant Non-small cell lung cancer
Thao Nguyen
Hanoi Medical University Hospital
Vietnam
A-0224
PE3-09
Comparison of ICI Plus Chemotherapy and Chemotherapy Alone in PD-L1-Negative Advanced NSCLC: A Real-World Analysis
Ji Young Park
Hallym University Sacred Heart Hospital
Korea
A-0213
PE3-10
Osimertinib in EGFRm NSCLC with Brain Metastases: Can Targeted Therapy Rival Surgery or Radiotherapy?
Keh Yee Tan
Sabah Women & Children Hospital
Malaysia
A-0185
PE3-11
Tepotinib Long-Term Efficacy and Safety in Patients with METex14 Skipping NSCLC: Updated Data from ≥3-Years Follow-Up in the VISION Trial
Myung-Ju Ahn
Samsung Medical Center Sungkyunkwan University School of Medicine
Korea
A-0165
PE3-12
Can circulating tumor DNA predict efficacy of pembrolizumab response in patients with metastatic non-small cell lung cancer?
Jatinkumar Veljibhai Dhanani
Gmers Medical College, Navsari
India
A-0157
PE3-13
Quality of Life Outcomes of the ATTLAS Study of Atezolizumab + Bevacizumab and Chemotherapy ( KCSG LU19-04) in EGFR/ALK- NSCLC
Eun Joo Kang
Korea University Guro Hospital
Korea
A-0147
PE3-14
CCT2 Coordinates Proteostasis and beta oxidation to Drive NSCLC Progression and Represents a Therapeutic Vulnerability
Sai Fung Yeung
The Chinese University Of Hong Kong
Hong Kong
A-0145
PE3-15
Response predictors for patients with EGFR-mutant metastatic non-small cell lung cancer receiving tyrosine kinase inhibitor treatment
Shweta Jatinkumar Dhanani
Gmers Medical College, Navsari
India
A-0141
PE3-16
Discovery of Potential KRAS G12C Inhibitors for NSCLC via Structure-Based Virtual Screening of Sotorasib Derivatives
Rian Ka Praja
Universitas Palangka Raya
Indonesia
A-0139
PE3-17
"CYFRA 21-1 as a Standalone Marker and its Role in a Multi-Biomarker Panel for Early Detection of NSCLC"
Afreen Mehdi
King George's Medical University
India
A-0137
PE3-18
Squamous Cell Lung Carcinoma with ROS1CD74 fusion 75% Rearrangement and PD-L1 50% CPS Overexpression: A Case Report
Edith Mari Timbol
Philippine General Hospital
Philippines
A-0106
PE3-19
The Application Potential of Exosomes in Immunotherapy for Lung Cancer
Pengpeng Lu
Medical School Of Nantong University
China
A-0098
PE3-20
A Twist in the Tumour Tale: The Unexpected Target in EGFR-Mutated Lung Squamous Cell Carcinoma
Izzati Rosli
National Cancer Institute Putrajaya Malaysia
Malaysia
Palliative Care
Palliative Care
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0247
PE3-21
Effectiveness of Music Therapy, Aromatherapy, and Quranic Recitation on Psychological and Physical Symptoms in Post-Chemotherapy Lung Cancer Patients in Indonesia
Yusril Yusril
Uin Sjech M. Djamil Djambek Bukittinggi
Indonesia
A-0242
PE3-22
Multidisciplinary Palliative Care in Lung Cancer: Enhancing Pain Management, Symptom Burden, and Psychological Well-being
Mutia Setia Ningsih
Andalas University
Indonesia
A-0214
PE3-23
Innovation Non-Pharmaceutical in Oncology: The Impact of Virtual Reality in Lung Cancer Care
Derizal Derizal
Ip Trisakti
Indonesia
A-0184
PE3-24
Malnutrition in Geriatric Lung Cancer Disease in Asia: An Investigation of Critical Risks of Nutritional Status
Abdul Igna Gopur Lukmana
The Pranala Institute
Indonesia
A-0183
PE3-25
High-VAF Tier-3 Variants and Post-Progression Survival in Oncogene-Addicted Stage IV NSCLC: A Retrospective Study
So-yun Kim
Chungnam National University Hospital
Korea
A-0140
PE3-26
Indonesian Community-Based Palliative Care Model Development: Applying Gotong Royong Philosophy and Community Support
Mega Dwi Septivani
Padang State Polytechnic
Indonesia
A-0089
PE3-27
Deep Learning Model for Predicting Immune Toxicity and Survival in End-Stage Lung Cancer from Peripheral Blood Single-Cell Data
Sahnaz Vivinda Putri
International University Semen Indonesia
Indonesia
Small Cell Lung Cancer / Neuroendocrine Tumors
Small Cell Lung Cancer / Neuroendocrine Tumors
Abstract No.
Poster No.
Abstract Title
Presenter Name
Affiliation
Country
A-0212
PE3-28
Genetic Analysis of EGFR and CYP3A4 Variants and Their Impact on Tyrosine Kinase Inhibitor Metabolism in Lung Cancer
Putrya Hawa
Indonesia Defense University
Indonesia
A-0168
PE3-29
Real-World Efficacy and Safety of First Line Chemo Immunotherapy in Extensive-Stage Small Cell Lung Cancer: Alignment With Pivotal Trials
Miran Han
Samsung Medical Center
Korea
A-0018
PE3-30
Self-oxygenating PROTAC Microneedles for Spatiotemporally-Tunable Protein Degradation and Enhanced Small cell lung cancer Therapy
Meng Hou
Shanghai Pulmonary Hospital
China
A-0226
PE3-31
Epidemiology and Survival Outcomes of Pulmonary Large Cell Neuroendocrine Carcinoma: A Population-Based Study